Zepbound leads to more weight loss than Wegovy, new study finds
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to new data released Wednesday by Eli Lilly, the maker of Zepbound.
Leptin by itself doesn't hold promise for weight loss — but a new mouse study suggests it could work in combination with ...
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
Gastric balloons are not new as a weight-loss aid, and stationary balloons filled with saline have long been approved for ...
Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...
Lohud.com, Westchester County on MSN1d
We revealed weight-loss drug inequality in New York. Here's why your stories matterOzempic, Wegovy, and other weight-loss drugs could make millions healthier, but access and affordability barriers abound.
Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback